Kedudukan dalam Saham
#41011
PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery... PLx Pharma Inc. is a U.S.-based entity leveraging its innovative drug delivery platform technology, having successfully transitioned into the commercial stage. The company's primary offerings include Vazalore 325 mg, which is formulated for individuals facing vascular incidents like heart attacks and clot-induced strokes, as well as for the management of pain and inflammation. Additionally, they provide Vazalore 81 mg in the form of liquid-filled aspirin capsules. Looking ahead, their product development pipeline features PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, both of which are in Phase I clinical trials for addressing pain, inflammation, and fever. PLx Pharma makes its products available to consumers through a variety of retail avenues, including pharmacies, major retailers, supermarkets, and online sales channels. Founded in 2002, PLx Pharma Inc. is headquartered in Sparta, New Jersey.
Harga Saham
$0.00575
Disegerakkan terakhir: 2023-05-23
Perubahan (1 hari)
-17.86%
Perubahan (1 tahun)
0.00%
Perdagangan PLx Pharma Inc. (PLXP)
Harga PLXP dengan permodalan pasaran b
Modal pasaran bagi PLx Pharma Inc.(PLXP)
Modal Pasaran: $51.30K
Sehingga August 2026, PLx Pharma Inc. mempunyai modal pasaran sebanyak $51.30K. Ini menjadikan PLx Pharma Inc. syarikat ke-41011th paling bernilai di dunia mengikut data kami. Kapitalisasi pasaran ialah nilai keseluruhan saham syarikat tersenarai yang berada dalam edaran dan lazimnya digunakan untuk menilai nilai syarikat tersebut.
Sejarah modal pasaran PLx Pharma Inc. dari 2014 hingga 2026
PLXP berbanding dengan 5 teratas yang paling popular stocks
| Harga PLXP |
|
Aset B |
Pasaran B |
Hasilnya |
|
|
|
|
$5.466T
|
+10,655,821,713.18%
|
|
|
|
|
$4.479T
|
+8,731,202,791.00%
|
|
|
|
|
$4.176T
|
+8,140,167,136.30%
|
|
|
|
|
$3.690T
|
+7,192,534,568.26%
|
|
|
|
|
$2.882T
|
+5,618,473,840.87%
|
